SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis

被引：4

作者：

Umapathysivam, Mahesh M. ^{[1
,2
,3
,4
,5
,6
]}

Morgan, Bethany ^{[3
,4
]}

Inglis, Joshua M. ^{[3
,5
]}

Meyer, Emily ^{[3
,4
,5
]}

Liew, Danny ^{[5
]}

Thiruvenkatarajan, Venkatesan ^{[7
]}

Jesudason, David ^{[3
,4
,5
,8
]}

机构：

[1] Royal Adelaide Hosp, Endocrine & Metab Unit, Port Rd, Adelaide, SA 5000, Australia

[2] Flinders Med Ctr, Southern Adelaide Diabet & Endocrine Serv, Adelaide, SA, Australia

[3] Queen Elizabeth Hosp, Endocrine Dept, Woodville, SA, Australia

[4] Royal Adelaide Hosp, Endocrine Dept, Adelaide, SA, Australia

[5] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia

[6] Univ Adelaide, Ctr Res Excellence Translating Nutr Sci Good Hlth, Adelaide, SA, Australia

[7] Queen Elizabeth Hosp, Anaesthet Dept, Woodville, SA, Australia

[8] Basil Hetzel Inst, Woodville, SA, Australia

来源：

JAMA NETWORK OPEN | 2024年 / 7卷 / 03期

关键词：

D O I：

10.1001/jamanetworkopen.2024.2744

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This cohort study examines the natural history and response to treatment of sodium glucose cotransporter 2 (SGLT2) inhibitor-associated ketoacidosis compared with that of type 1 diabetes-associated ketoacidosis.

引用

页数：4

共 50 条

[1] SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis
Anis, K.
Eldib, A.
Mitri, J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[2] EMA reviewing SGLT2 inhibitor-associated diabetic ketoacidosis
Reactions Weekly, 2015, 1557 (1) : 2 - 2
[3] A Territory-Wide Study of SGLT2 Inhibitor-Associated Postoperative Diabetic Ketoacidosis in Type 2 Diabetes Patients
Lui, David T. W.
Wu, Tingting
Liu, Xiaodong
Au, Chi Ho
Lee, Chi Ho
Fung, Man Him Matrix
Woo, Yu Cho
Tan, Kathryn C.
Wong, Carlos K.
DIABETES, 2022, 71
[4] A Population-Based Study of SGLT2 Inhibitor-Associated Postoperative Diabetic Ketoacidosis in Patients with Type 2 Diabetes
Lui, David Tak Wai
Wu, Tingting
Au, Ivan Chi Ho
Liu, Xiaodong
Fung, Matrix Man Him
Lee, Chi Ho
Fong, Carol Ho Yi
Woo, Yu Cho
Lang, Brian Hung Hin
Tan, Kathryn Choon Beng
Wong, Carlos King Ho
DRUG SAFETY, 2023, 46 (01) : 53 - 64
[5] A Population-Based Study of SGLT2 Inhibitor-Associated Postoperative Diabetic Ketoacidosis in Patients with Type 2 Diabetes
David Tak Wai Lui
Tingting Wu
Ivan Chi Ho Au
Xiaodong Liu
Matrix Man Him Fung
Chi Ho Lee
Carol Ho Yi Fong
Yu Cho Woo
Brian Hung Hin Lang
Kathryn Choon Beng Tan
Carlos King Ho Wong
Drug Safety, 2023, 46 : 53 - 64
[6] SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis
Goldenberg, Ronald M.
Berard, Lori D.
Cheng, Alice Y. Y.
Gilbert, Jeremy D.
Verma, Subodh
Woo, Vincent C.
Yale, Jean-Francois
CLINICAL THERAPEUTICS, 2016, 38 (12) : 2654 - 2664
[7] Inpatient case characteristics of SGLT2 inhibitor-associated diabetic ketoacidosis: a retrospective study
Yang, Zhongpei
Zhang, Weixia
Chen, Hefeng
Peng, Qianwen
EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024,
[8] SGLT-2 inhibitor-associated euglycemic ketoacidosis in Denmark
Johansson, Karl Sebastian
Bogevig, Soren
Christensen, Mikkel B.
CLINICAL TOXICOLOGY, 2024, 62 : 117 - 117
[9] Ketoacidosis in Type 2 Diabetes with and without SGLT2 Inhibitor Therapy
Koerbel, Theresa
Zitterl, A.
Jagoutz, T.
Peric, S.
Stulnig, T. M.
WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S765 - S765
[10] Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data
Blau, Jenny E.
Tella, Sri Harsha
Taylor, Simeon I.
Rother, Kristina I.
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33 (08)

← 1 2 3 4 5 →